Medicare Enrolled
Dr. Kathryn Alguire, M.D.
Medical Oncology · Norton Shores, MI
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Alguire from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Alguire?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Alguire
Dr. Kathryn Alguire is a medical oncology specialist in Norton Shores, MI, with 21 years of NPI registration. Based on federal Medicare data, Dr. Alguire performed 57,056 Medicare services across 2,320 unique beneficiaries.
Between the years covered by Open Payments, Dr. Alguire received a total of $5,538 from 60 pharmaceutical and/or device companies across 311 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Alguire is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years in practice
▲ Top 13% volume in MI
$5,538 industry payments
Medicare Practice Summary
Medicare Utilization ↗57,056
Medicare services
Top 13% in MI for medical oncology
2,320
Unique beneficiaries
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,717 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
29,250 | $1 | $2 |
| Paclitaxel chemotherapy injection | 9,030 | $0 | $0 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
7,350 | $0 | $3 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,252 | $0 | $1 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,310 | $1 | $31 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,012 | $8 | $15 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
941 | $8 | $26 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
774 | $10 | $35 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
558 | $11 | $34 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
527 | $59 | $133 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
437 | $94 | $292 |
| Pegfilgrastim-apgf injection An injection of pegfilgrastim-apgf, a biosimilar medication. The dose specified is 0.5 mg. |
336 | $79 | $253 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
290 | $88 | $189 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
258 | $6 | $25 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
211 | $74 | $70 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
200 | $2 | $8 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
190 | $52 | $123 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
182 | $10 | $38 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
156 | $21 | $47 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
128 | $7 | $23 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
121 | $1 | $2 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
102 | $47 | $142 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
100 | $42 | $151 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
93 | $9 | $32 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
92 | $2 | $4 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
76 | $16 | $57 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
75 | $1 | $2 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
73 | $21 | $66 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
70 | $24 | $84 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
67 | $13 | $46 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 66 | $20 | $71 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
58 | $41 | $100 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
52 | $9 | $26 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
49 | $23 | $83 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
48 | $5 | $16 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
46 | $15 | $41 |
| Injection, alteplase recombinant, 1 mg | 40 | $67 | $132 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 125 | 37 | $20 | $71 |
| New patient office visit, complex (60-74 min) | 36 | $159 | $326 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
33 | $134 | $304 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
32 | $6 | $20 |
| Serum protein measurement A blood test that measures the total amount of protein in the serum. It helps evaluate overall health and nutritional status. |
31 | $11 | $37 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
30 | $29 | $101 |
| Iron level test | 30 | $6 | $22 |
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
26 | $4 | $11 |
| Hepatitis B core antibody test A blood test that measures the level of antibodies to the hepatitis B core antigen. This test helps determine if a person has been infected with the hepatitis B virus. |
25 | $12 | $30 |
| Hepatitis B surface antibody test A blood test that measures the level of antibodies against the hepatitis B surface antigen. This test is used to check for immunity to hepatitis B or to verify the effectiveness of the hepatitis B vaccine. |
25 | $11 | $27 |
| Hepatitis B surface antigen test A blood test that uses an immunoassay technique to detect the presence of the hepatitis B surface antigen. This test identifies whether the hepatitis B virus is currently present in the body. |
25 | $10 | $26 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
23 | $15 | $51 |
| Central venous tube declotting A procedure to clear a blockage or clot from a central venous catheter to restore its function. |
20 | $22 | $84 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
19 | $130 | $264 |
| Transferrin level test A blood test that measures the amount of transferrin, a protein that binds to and transports iron in the body. |
17 | $12 | $40 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
16 | $16 | $55 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
11 | $14 | $50 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
52.9% high complexity
38.7% medium
8.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,538
Total received (2018-2024)
Avg $791/year across 7 years
Top 40% in MI for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
60
Companies
311
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,275 (95.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$262 (4.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$930
2023
$1,159
2022
$1,076
2021
$43
2020
$314
2019
$783
2018
$1,233
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Gilead Sciences, Inc.
$132
Merck Sharp & Dohme LLC
$113
AstraZeneca Pharmaceuticals LP
$100
JAZZ PHARMACEUTICALS INC.
$74
ABBVIE INC.
$63
Eisai Inc.
$55
SpringWorks Therapeutics, Inc.
$47
Daiichi Sankyo Inc.
$44
PUMA BIOTECHNOLOGY, INC.
$40
Sumitomo Pharma America, Inc.
$39
GENZYME CORPORATION
$30
Regeneron Healthcare Solutions, Inc.
$26
GlaxoSmithKline, LLC.
$24
Astellas Pharma US Inc
$21
ARRAY BIOPHARMA INC
$20
SOBI, INC
$20
PFIZER INC.
$20
Genentech USA, Inc.
$17
Stemline Therapeutics Inc.
$17
E.R. Squibb & Sons, L.L.C.
$16
Celgene Corporation
$14
Top 3 companies account for 37.1% of 2024 payments
All-time payments by company (2018-2024) ›
E.R. Squibb & Sons, L.L.C.
$383
Novartis Pharmaceuticals Corporation
$354
Gilead Sciences, Inc.
$351
Genentech USA, Inc.
$347
PFIZER INC.
$337
AstraZeneca Pharmaceuticals LP
$292
Merck Sharp & Dohme LLC
$254
Amgen Inc.
$213
Astellas Pharma US Inc
$188
Eisai Inc.
$153
Pharmacyclics LLC, An AbbVie Company
$143
EMD Serono, Inc.
$127
GlaxoSmithKline, LLC.
$125
JAZZ PHARMACEUTICALS INC.
$125
Pharmacyclics LLC, an AbbVie Company
$123
GENZYME CORPORATION
$118
Merck Sharp & Dohme Corporation
$115
Celgene Corporation
$108
Ipsen Biopharmaceuticals, Inc
$96
Janssen Biotech, Inc.
$94
Janssen Pharmaceuticals, Inc
$93
Exelixis Inc.
$85
Takeda Pharmaceuticals U.S.A., Inc.
$83
Daiichi Sankyo Inc.
$82
ABBVIE INC.
$80
EISAI INC.
$80
Foundation Medicine, Inc.
$62
Seagen Inc.
$58
Sumitomo Pharma America, Inc.
$56
Kite Pharma, Inc.
$54
Alexion Pharmaceuticals, Inc.
$52
Lilly USA, LLC
$48
SpringWorks Therapeutics, Inc.
$47
Incyte Corporation
$46
Regeneron Healthcare Solutions, Inc.
$44
PUMA BIOTECHNOLOGY, INC.
$40
BeiGene USA, Inc.
$37
Rigel Pharmaceuticals, Inc.
$35
TESARO, Inc.
$28
Bayer Healthcare Pharmaceuticals Inc.
$28
MACROGENICS, INC.
$25
INSYS Therapeutics Inc
$25
Lexicon Pharmaceuticals, Inc.
$25
Sun Pharmaceutical Industries Inc.
$24
ARRAY BIOPHARMA INC
$20
SOBI, INC
$20
Taiho Oncology, Inc.
$19
Puma Biotechnology, Inc.
$19
Aadi Bioscience, Inc.
$18
NOVARTIS PHARMACEUTICALS CORPORATION
$18
Stemline Therapeutics Inc.
$17
SERVIER PHARMACEUTICALS LLC
$16
ADC Therapeutics America, Inc.
$16
Helsinn Therapeutics (U.S.), Inc.
$15
TerSera Therapeutics LLC
$15
Seattle Genetics, Inc.
$14
AbbVie, Inc.
$14
Novo Nordisk Inc
$12
Bayer HealthCare Pharmaceuticals Inc.
$12
Agios Pharmaceuticals, Inc.
$11
Top 3 companies account for 19.6% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AKYNZEO · Alecensa · Avastin · BAVENCIO · BLENREP · BOSULIF · BRUKINSA · Bavencio · Blincyto · CALQUENCE · CERDELGA · CYRAMZA · Cabometyx · DOPTELET · ELIQUIS · ELITEK · EMPLICITI · ENHERTU · EPKINLY · ERLEADA · Enhertu · FASLODEX · FOUNDATIONONE · Fyarro · GAZYVA · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · Kadcyla · LIBTAYO · LORBRENA · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MARGENZA · MEKINIST · NINLARO · NOXAFIL · Neulasta · Nplate · OGSIVEO · OJJAARA · OPDIVO · OPDUALAG · ORGOVYX · Orserdu · PREVYMIS · PROMACTA · PROSTATE CANCER - DISEASE · Perjeta · Phesgo · Pomalyst · Prolia · REBINYN · REBLOZYL · Revlimid · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · SUTENT · SYNDROS · Stivarga · TAGRISSO · TECENTRIQ · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tazverik · Tibsovo · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · Venclexta · Vitrakvi · XALKORI · XARELTO · XTANDI · Xermelo · Xospata · YONSA · ZEJULA · ZEPZELCA · Zoladex · Zydelig
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Medical oncologists within 10 mi
2
Per 100K population
1.1
County median income
$63,495
Nearest hospital
TRINITY HEALTH MUSKEGON HOSPITAL
4.4 mi
4.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Alguire is a mixed practice specialist, with above-average Medicare volume (top 13% in MI), with low-engagement industry engagement, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Alguire experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Alguire performed 29,250 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Alguire receive payments from pharmaceutical companies?
Yes. Dr. Alguire received a total of $5,538 from 60 companies across 311 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Alguire's costs compare to other medical oncologists in Norton Shores?
Dr. Alguire's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Alguire) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Norton Shores
Browse medical oncologists in Norton Shores ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in MI
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in MI
Which MI medical oncologists receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Gilead Sciences, Inc. Payments to Doctors
See all physicians who received payments from Gilead Sciences, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology